Mpox in the 21st Century
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 3037
Special Issue Editor
Interests: mycobacterial diseases (TB and nontuberculous mycobacteria); respiratory viruses (influenza, RSV, COVID-19); pox infections; general clinical infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Mpox is one of the four pathogenic orthopoxvirus species. Mpox has two genetic clades, the Central African and West African clades, which have caused outbreaks in the corresponding regions of Africa since 1970. The first Mpox cases outside Africa were detected in the United States in 2003, suggesting the potential for Mpox clades to spread widely. In fact, Mpox recently caused a large outbreak involving 110 countries and locations that led the World Health Organization to declare a global health emergency in July 2022, illustrating that Mpox continues to be a serious public health threat.
In this Special Issue of Pathogens, we invite you to submit research articles, review articles, short communications, and case series or case reports on Mpox. Suggested topics include, but are not limited to, clinical presentations in individuals with different risk factors; animal reservoirs and transmission; treatment, vaccines and their impact; and ongoing studies for the potential improvement of strategies to control future outbreaks.
Dr. Getahun Abate
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Mpox
- monkeypox
- outbreak
- treatment
- vaccine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
